ascididemin has been researched along with sanguinarine in 1 studies
| Studies (ascididemin) | Trials (ascididemin) | Recent Studies (post-2010) (ascididemin) | Studies (sanguinarine) | Trials (sanguinarine) | Recent Studies (post-2010) (sanguinarine) |
|---|---|---|---|---|---|
| 23 | 0 | 10 | 675 | 37 | 290 |
| Protein | Taxonomy | ascididemin (IC50) | sanguinarine (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 7.08 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 2 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.22 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 2 | |
| Transcription factor p65 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, T; Pati, S; Swain, SS | 1 |
1 other study(ies) available for ascididemin and sanguinarine
| Article | Year |
|---|---|
Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |